0001388410-19-000152.txt : 20191119 0001388410-19-000152.hdr.sgml : 20191119 20191119171215 ACCESSION NUMBER: 0001388410-19-000152 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190701 FILED AS OF DATE: 20191119 DATE AS OF CHANGE: 20191119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ARENA PAUL R CENTRAL INDEX KEY: 0001275657 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52534 FILM NUMBER: 191232092 MAIL ADDRESS: STREET 1: 1327 OCEAN AVE SUITE M CITY: SANTA MONICA STATE: CA ZIP: 90401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PARALLAX HEALTH SCIENCES, INC. CENTRAL INDEX KEY: 0001388410 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 464733512 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1327 OCEAN AVENUE, SUITE M CITY: SANTA MONICA STATE: CA ZIP: 90401 BUSINESS PHONE: 310-899-4442 MAIL ADDRESS: STREET 1: 1327 OCEAN AVENUE, SUITE M CITY: SANTA MONICA STATE: CA ZIP: 90401 FORMER COMPANY: FORMER CONFORMED NAME: ENDEAVOR POWER CORP. DATE OF NAME CHANGE: 20140110 FORMER COMPANY: FORMER CONFORMED NAME: Endeavor Power Corp DATE OF NAME CHANGE: 20090105 FORMER COMPANY: FORMER CONFORMED NAME: Endeavor Uranium, Inc. DATE OF NAME CHANGE: 20071113 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2019-07-01 0 0001388410 PARALLAX HEALTH SCIENCES, INC. PRLX 0001275657 ARENA PAUL R 1327 OCEAN AVE SUITE M SANTA MONICA CA 90401 1 1 0 0 CEO, President COMMON STOCK (RESTRICTED) 2019-07-01 5 A 0 E 2375000 0.001 A 7375000 D COMMON STOCK (RESTRICTED) 2019-09-30 5 P 0 E 1600000 0.0625 A 8975000 D WARRANTS 0.25 2019-09-30 5 A 0 E 1600000 0 A 2019-09-30 2022-09-30 COMMON STOCK 1600000 6645000 D Granted pursuant to Employment Agreement dated July 1, 2017. Total restricted stock grant 10,000,000 common shares, of which a total of 7,500,000 have vested, and 2,500,000 will vest upon positive earnings. Issued in connection with a Securities Purchase Agreement dated September 30, 2019, for proceeds in the amount of $100,000, paid by way of reduction in accrued compensation. Warrants granted in connection with Securities Purchase Agreement dated September 30, 2019. PAUL R. ARENA 2019-11-19